to commercialize a series of proprietary neuromuscular blocking agents
that may benefit patients and the medical community, said Dr.
Intravenous (I/V) induction agents, I/V fluids, latex products, neuromuscular blocking agents
, antibiotics and blood or blood products or any agent used perioperatively may be implicated as a causative agent.
To ascertain the cross reactivity with other neuromuscular blocking agents
, allergic skin tests to succinylcholine, rocuronium and atrcurium was conducted.
Furthermore, Tambocor is the only sodium channel blocking agent
in Japan to be approved for the treatment of tachyarrythmia in pediatric patients.
The Global Congestive Heart Failure Drugs market can be divided into four segments: ACE Inhibitors/ARB Antagonists, Beta-adrenergic Receptor Blocking Agents
, Diuretics, and Inotropic Drugs/Vasodilators.
1-3) Therefore, general anesthesia (4,5) or local neuromuscular blocking agents
(NMBA) have been used.
In conclusion, there are situations where the use of neuromuscular blocking agents
may be avoided, but there are also other situations where they are mandatory, and other cases where they may be considered as an option.
Upper airway obstruction with respiratory compromise may be due to neuromuscular blocking agents
(NMBA) alone, but various disease states, anaesthetic agents, benzodiazepines and opioid drugs may also contribute.
The researchers' next step will be to create a mouse model with mixed cell glioblastoma that can be used to test different therapeutics, inhibitors and blocking agents
In the last issue neuromuscular blocking agents
(NMBA) were discussed in terms of availability and indications of use.
of Cape Town, South Africa) and Gersh (medicine, Mayo Clinic) have edited the contributions of esteemed colleagues to cover such topics as beta blocking agents
, nitrates and antianginals, diuretics, angiotensin-converting enzymes and other common medications for the treatment of heart disease.
Because of the potential effects of beta-adrenergic blocking agents
on blood pressure and pulse, these agents should be used with caution in patients with cerebrovascular insufficiency.
receptor blocking agents
are useful for treating lymphocyte-mediated immunological diseases, and more particularly, for inhibiting Th1 cell-mediated immune responses.
33) Neuromuscular blocking agents
interfere with the transmission of nerve impulses at the receptor sites of all skeletal muscle.
Neuromuscular blocking agents
(NMBAs) are considered high-alert drugs: ".